Yatharth Hospital & Trauma Care Services Ltd. announced robust financial results for the second quarter and half-year ended September 30, 2026. The company reported a 52% year-on-year revenue increase to ₹4,314 million for Q2 FY27, driven by contributions from new hospitals and strong momentum in mature facilities. EBITDA also saw a significant 50% YoY jump to ₹1,020 million. The company also announced a strategic partnership with Advent International for a primary capital investment of ₹3,150 crore to fund future expansion.
Strong Financial Performance Reported
Yatharth Hospital and Trauma Care Services Ltd. today announced its financial results for the quarter and half year ended September 30, 2026. The company demonstrated strong performance, with revenue reaching a record ₹4,314 million in Q2 FY27, marking a 52% increase year-on-year and a 10% increase quarter-on-quarter. EBITDA also showed significant growth, up 50% year-on-year to ₹1,020 million.
Key Highlights for Q2 FY27
- Revenue reached a record ₹4,314 mn, up 52% YoY and 10% QoQ. New hospitals contributed ₹1,205 mn, accounting for 28% of Group revenue, with mature hospitals growing 24% YoY. Total volumes increased by 50% YoY, with inpatient volumes up 67% YoY.
- Group ARPOB (Average Revenue Per Occupied Bed) reached ₹35,948, up 11% YoY.
- EBITDA recorded ₹1,020 mn, up 50% YoY and 11% QoQ. EBITDA margins improved sequentially by 30 bps. Acquisitions, such as Faridabad Sector-20 and Agra, became EBITDA positive in H1 FY27. Adjusted EBITDA stood at 28%.
- Profit After Tax (PAT) was ₹485 mn, up 17% YoY. Cash Profits (PAT plus depreciation) rose 36% YoY to ₹816 mn.
- Operating cash flow (pre-tax) was up 49% YoY in H1 FY27, and total cash and bank balances stood at ₹4,289 mn.
Strategic Partnership for Growth
Yatharth Hospitals has entered into a definitive agreement with Advent International for a primary capital investment of ₹3,150 crore. This investment, through the issuance of equity shares and warrants, is subject to regulatory approvals. Advent International is expected to hold approximately 24.9% on full conversion. This partnership is poised to support the acceleration of the company’s expansion plans to approximately 7,000-8,000 beds over the next few years, bringing valuable global healthcare experience and strategic perspective.
Management Commentary
Mr. Yatharth Tyagi, Whole Time Director, stated, “Q2 FY2027 marks a defining milestone in Yatharth Hospitals’ growth journey. Our performance continues to reinforce the strength of our underlying business model and our ability to execute consistently. Our quarterly revenue and profits have nearly tripled since our listing in 2023. Our strategic partnership with Advent International represents a strong endorsement of the platform we have built, our execution capabilities and the significant growth opportunity ahead.”
Earnings Conference Call
The management of Yatharth Hospitals will host a conference call on Wednesday, November 4, 2026, at 11:00 am IST to discuss the Q2 & H1 FY27 results and answer participant questions.
Source: BSE
